We are live on ! Find out more
IVLAV

Index Venture Life Associates VI Portfolio holdings

AUM $396M
1-Year Est. Return 176.22%
This Fund
S&P 500
This Quarter Est. Return
-32.57%
1 Year Est. Return
+176.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$112M
AUM Growth
Cap. Flow
+$134M
Cap. Flow %
119.49%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$134M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$112M 100%
+9,961,789
New +$134M

Similar funds

Index Venture Life Associates VI's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Index Venture Life Associates VI, which disclosed 1 position worth $112M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Centessa Pharmaceuticals: 9,961,789 shares worth $112M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Index Venture Life Associates VI's largest Q4 2021 buy was Centessa Pharmaceuticals: 9,961,789 shares worth $112M.
  • Index Venture Life Associates VI's ten largest holdings make up 100% of its $112M portfolio in Q4 2021.
  • Index Venture Life Associates VI disclosed 1 position in Q4 2021, its first 13F filing on record.

Based on Index Venture Life Associates VI's 13F filing for Q4 2021, filed 14 Feb 2022.